rs121909209
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000358.3(TGFBI):c.1664G>A(p.Arg555Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,396 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R555W) has been classified as Pathogenic.
Frequency
Consequence
NM_000358.3 missense
Scores
Clinical Significance
Conservation
Publications
- epithelial-stromal TGFBI dystrophyInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
- granular corneal dystrophy type IInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
- granular corneal dystrophy type IIInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
- lattice corneal dystrophy type IInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- Reis-Bucklers corneal dystrophyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
- Thiel-Behnke corneal dystrophyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
- epithelial basement membrane dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TGFBI | NM_000358.3 | c.1664G>A | p.Arg555Gln | missense_variant | Exon 12 of 17 | ENST00000442011.7 | NP_000349.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TGFBI | ENST00000442011.7 | c.1664G>A | p.Arg555Gln | missense_variant | Exon 12 of 17 | 1 | NM_000358.3 | ENSP00000416330.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461396Hom.: 0 Cov.: 33 AF XY: 0.00000138 AC XY: 1AN XY: 726980 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Thiel-Behnke corneal dystrophy Pathogenic:2
- -
- -
not provided Pathogenic:2
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 555 of the TGFBI protein (p.Arg555Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal dominant corneal dystrophy (PMID: 22355247). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 7867). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt TGFBI protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects TGFBI function (PMID: 21135107). For these reasons, this variant has been classified as Pathogenic. -
TGFBI: PS2, PM2, PM5, PS4:Moderate, PP1, PS3:Supporting, BP4 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at